Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer

Cancer Investigation

Volumn 27, Issue 9, 2009, Pages 924-931

  Miteva, L ^a   Stanilov, N ^a   Deliysky, T ^b   Mintchev, N ^a   Stanilova, S ^a,c  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

^c TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

Cancer genetics; Colorectal and anal cancer; Tumor immunology

Indexed keywords

INTERLEUKIN 12P40;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

3' UNTRANSLATED REGIONS; AGED; BULGARIA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; MALE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; UP-REGULATION;

EID: 70350191740     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900902918486     Document Type: Article

References (27)

1. Lin, W.W.; Karin, M.A. Cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117(5), 1175-1183.
2. Hoelscher, C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immuno 2004, 193(1), 1-17.
3. Han, S.S.; Cho, E.Y.; Lee, T.S.; Kim, J.W.; Park, N.H.; Song, Y.S.; Kim, J.G.; Lee, H.P.; Kang, S.B. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical caner in Korean women. Eur J Obstet Gynecol Reprod Biol 2008, 140(1), 71-75.
4. Navaglia, F.; Basso, D.; Zambon, C.F.; Ponzano, E.; Caenazzo, L.; Gallo, N.; Falda, A.; Belluco, C.; Fogar, P.; Greco, E.; Di Mario, F.; Rugge, M.; Plebani, M. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H. pyloriinfected individuals. J Med Genet 2005, 42(6), 503-510.
5. Howell,W.M.; Turner, S.J.; Theaker, J.M.; Bateman, A.C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 2003, 30(6), 409-414.
6. Nieters, A.; Yuan, J.M.; Sun, C.L.; Zhang, Z.Q.; Stoehlmacher, J.; Govindarajan, S.; Yu, M.C. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 2005, 103(4), 740-748.
7. Morahan, G.; Huang, D.; Ymer, S.I.; Cancilla, M.R.; Stephen, K.; Dabadghao, P.; Werther, G.; Tait, B.D.; Harrison, L.C.; Colman, P.G. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001, 27(2), 218-221.
8. Seegers, D.; Zwiers, A.; Strober,W.; Pena, A.S.; Bouma, G. A TaqI polymorphism in the 3-UTR of the IL-12p40 gene correlates with increased IL-12 secretion. Genes Immun 2002, 3(7), 419-423.
9. Stanilova, S.; Miteva, L. Taq-I polymorphism in 3-UTR of the IL- 12 and association with IL-12p40 production from human PBMC. Genes Immun 2005, 6(4), 364-366.
10. Morahan, G.; Huang, D.; Wu, M.; Holt, B.J.; White, G.P.; Kendall, G.E.; Sly, P.D.; Holt, P.G. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 2002, 360(9331), 455-459.
11. Muller-Berghaus, J.; Kern, K.; Paschen, A.; Nguyen, X.D.; Klüter, H.; Morahan, G.; Schadendorf, D. Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun 2004, 5(5), 431-434.
12. Stanilova, S.; Miteva, L.; Prakova, G. IL-12Bpro and GSTP1 polymorphisms in association with silicosis. Tissue Antigens 2008, 71(2), 169-174.
13. O'Hara, R.J.; Greenman, J.; MacDonald, A.W.; Gaskell, K.M.; Topping, K.P.; Duthie, G.S.; Kerin, M.J.; Lee, P.W.; Monson, J.R. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res 1998, 4(8), 1943-1948. (Pubitemid 28369179)
14. Shibata, M.; Nezu, T.; Kanou, H.; Abe, H.; Takekawa, M.; Fukuzawa, M. Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer. J Clin Gastroenterol 2002, 34(4), 416-420.
15. Nakayama, Y.; Sako, T.; Shibao, K.; Onitsuka, K.; Nagashima, N.; Hirata, K.; Nagata, N.; Itoh, H. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer. Anticancer Res 2000, 20(6A), 4097-4102.
16. Inoue, Y.; Nakayama, Y.; Minagawa, N.; Katsuki, T.; Nagashima, N.; Matsumoto, K.; Shibao, K.; Tsurudome, Y.; Hirata, K.; Nagata, N.; Itoh, H. Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer. Anticancer Res 2005, 25(5), 3541-3546.
17. Murakami, S.; Okubo, K.; Tsuji, Y.; Sakata, H.; Hamada, S.; Hirayama, R. Serum interleukin-12 levels in patients with gastric cancer. Surg Today 2004, 34(12), 1014-1019.
18. Hou, L.; El-Omar, E.M.; Chen, J.; Grillo, P.; Rabkin, C.S.; Baccarelli, A.; Yeager, M.; Chanock, S.J.; Zatonski, W.; Sobin, L.H.; Lissowska, J.; Fraumeni, J.F., Jr.; Chow, W.H. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007, 28(1), 118-1113
19. Theodoropoulos, G.; Papaconstantinou, I.; Felekouras, E.; Nikiteas, N.; Karakitsos, P.; Panoussopoulos, D.; Lazaris, A.Ch.; Patsouris, E.; Bramis, J.; Gazouli, M. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 2006, 12(31), 5037-5043.
20. Landi, S.; Moreno, V.; Gioia-Patricola, L.; Guino, E.; Navarro, M.; de Oca, J.; Capella, G.; Canzian, F.; Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 2003, 63(13), 3560-3566.
21. García-Gonźalez, M.A.; Lanas, A.; Wu, J.; Benito, R.; Santolaria, S.; Crusius, B.;Peña, S. Lack of association of IL-12p40 gene polymorphism with peptic ulcer disease. Hum Immunol 2005, 66(1), 72-76.
22. Seegers, D.; Borm, M.E.; van Belzen, M.J.; Mulder, C.J.; Bailing, J.; Crusius, J.B.; Meijer, J.W.; Wijmenga, C.; Peña, A.S.; Bouma, G. IL12B and IRF1 gene polymorphisms and susceptibility to celiac disease. Eur J Immunogenet 2003, 30(6), 421-425.
23. D'Andrea, A.; Rengaraju, M.; Valiante, N.M.; Chehimij, J.; Kubin, M.; Aste, M.; Chan, S.; Kobatashi, M.; Young, D.; Nickbarg, E.; Chizzonite, R.; Wolf, S.; Trinchieri, G. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992, 176(5), 1387-1398.
24. Colombo, M.P.; Trinchieri, G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 2002, 13(2), 155-168.
25. Lo, C.H.; Lee, S.C.; Wu, P.Y.; Pan, W.Y.; Su, J.; Cheng, C.W.; Rof- fler, S.R.; Chiang, B.L.; Lee, C.N.; Wu, C.W.; Tao, M.H. Antitumor and antimetastatic activity of IL-23. J Immunol 2003, 171(2), 600-607.
26. Hao, J.S.; Shan, B.E. Immune enhancement and anti-tumour activity of IL-23. Cancer Immunol Immunother 2006, 55(11), 1426-1431.
27. Langowski, J.L.; Zhang, X.; Wu, L.; Mattson, J.D.; Chen, T.; Smith, K.; Basham, B.; McClanahan, T.; Kastelein, R.A.; Oft, M. IL-23 promotes tumour incidence and growth. Nature 2006, 442(7101), 461-465.